conditions where hypoxia may be prominent. To study the effects of vasodilator therapy on organ oxygen delivery we measured blood flow (using radioactive microspheres) and arterial oxygen content in six chronically catheterized newborn lambs. Cardiac output and its distribution were measured during normoxia, hypoxia (10% O2 and 5% C02), and hypoxia with a nitroprusside infusion. Hypoxia decreased oxygen content but did not change heart rate, mean blood pressure, or cardiac output. When nitroprusside was infused during hypoxemia, oxygen content and heart rate were not affected, but mean arterial blood pressure fell (39% decrease). During hypoxemia, blood flow increased to the heart, brain, and carcass but decreased to the gastrointestinal tract. When nitroprusside was infused during hypoxemia, blood flow decreased to the heart, brain, kidneys, and carcass. Oxygen delivery (arterial Oz content x blood flow) decreased to the brain as well as to kidneys, stomach, and carcass when nitroprusside was given to the hypoxemic lamb. (Pediatr Res 19: 15-18, 1985)
Hypoxemia often accompanies neonatal cardiopulmonary disease. Such common problems as hyaline membrane disease, pneumonia, aspiration syndromes, cyanotic congenital heart disease, and persistent fetal circulation may present with hypoxemia as a prominent finding (8, 14, 20) . When conventional therapy (high inspired oxygen concentration and mechanical ventilation) fails to increase arterial Po2, phannacologic agents have been used. In general, drug therapy is aimed at increasing arterial oxygen content by increasing pulmonary blood flow and thus is employed primarily when pulmonary blood flow is thought to be reduced as a result of pulmonary arterial vasoconstriction.
Sodium nitroprusside is a potent, direct-acting vasodilator which has been used for systemic hypertension (16) , pulmonary hypertension (7) , and congestive heart failure (6, 17) . Although experience with nitroprusside in the neonate is limited, two case reports (1, 4) have suggested that nitroprusside may have a therapeutic role in decreasing the high pulmonary vascular resistance of hyaline membrane disease.
Nitroprusside is an iron-coordinated complex surrounded by cyanide groups with a single nitroso group (16) . The drug is metabolized in the liver to cyanide which is then quickly con-verted to thiocyanate. Cyanide and thiocyanate may have toxic effects which result in tissue hypoxia and resultant metabolic acidosis. Thiocyanate levels of 10-20 mg/100 m1 (16) result in adverse clinical symptoms. As toxic products accumulate during infusion, hazard increases when the infusion is prolonged.
Further information about the response of the newborn's systemic circulation to vasodilator therapy, especially under hypoxemic conditions, would help to show when their use is appropriate. The purpose of this experiment is to examine the effect of nitroprusside on the distribution of tissue blood flow and oxygen delivery during hypoxemia.
MATERIALS AND METHODS

Animals.
We operated on six lambs, 3-4 days of age, using ketamine (Ketalar, Parke-Davis) (10 mg/kg im), and local (1% xylocaine) anesthesia. In each animal, polyvinyl catheters (id. 0.76 mm; 0.d. 1.22 mm) were placed into both hind limb arteries and advanced to the descending aorta. We also placed a catheter in one hind limb vein and advanced it to the inferior vena cava. Through a neck incision, a catheter was placed in the left ventricle via the carotid artery. All catheters were filled with heparin (1000 unit/ml) and were brought subcutaneously to the lamb's back where they were stored in a gauze pouch. The lambs were allowed to recover until fully awake and then returned to their pens where they were free to feed. Two to three days after surgery, at a time when intracardiac and ductal shunts are no longer detectable (19) , the lambs were brought back to the laboratory and placed in a plexiglass box where they were allowed to adapt to these surroundings prior to study. The animals were unanesthetized and unrestrained. The laboratory is maintained at an ambient temperature between 2 1-22" C.
Experimental protocol. One hind limb arterial catheter was connected to a Statham P23Db pressure transducer to measure blood pressure. Heart rate was obtained from a cardiotachometer coupled to the blood pressure channel. Both measurements were recorded continuously on a Beckman R611 direct writing recorder. Control hematocrit, pH, and arterial blood gas samples were obtained from a hind limb arterial catheter (0.5 ml). Hematocrit was measured by the microhematocrit method. Blood gas samples were measured using a Corning blood gas meter (Corning Instruments, Corning, NY). In addition, arterial oxygen content samples (0.2 ml) were obtained anaerobically and immediately analyzed on a Lex-02-Con (Lexington Instruments, Waltham, MA) oxygen analyzer. Serum samples (1 ml) were obtained for cyanide [quantitative assay using the Conway microdiffusion method (lo)] and thiocyanate [spectrophotometric method of Aldridge (2)]. Immediately after these samples were obtained, approximately 1 x lo6 microspheres (15 pm diameter) labeled with 125-1, 85-SR, or 46-SC were injected into the left ventricular catheter over 20 s (1 8) . A blood reference sample was withdrawn from the remaining hind limb arterial catheter using a withdrawal pump (rate = 3.8 ml/min), beginning before the microsphere injection and ending 60 s after the injection catheter was flushed with saline (1 5). The animal was then made hypoxemic by introducing a gas mixture of 9-10% O2 and 5% C02 (to maintain constant arterial Pco2) into the plexiglass box. The inflowing gas was cooled in order to maintain the temperature within the plexiglass box at ambient room temperature. After a period of equilibration (30 min), samples were again obtained for all studies outlined above (except cyanide and thiocyanate) and a second microsphere injection (using an alternately labeled isotope) and reference withdrawal were done. Sampling and microsphere injections were accomplished within 5 min. Finally, an infusion of sodium nitroprusside was begun at 20 pg/kg/min (the dose needed to decrease mean arterial blood pressure by approximately one-third) through the hind limb venous catheter. When the arterial blood pressure had equilibrated (30 min), samples for pH, arterial blood gases, O2 content, cyanide, and thiocyanate were obtained and a third microsphere injection (with an isotope labeled differently from the first two) and reference withdrawal were performed. Reference artery blood samples contained more than 2700 microspheres to ensure a blood flow measurement error of less than 5% at the 99% confidence limits (5) . In a preliminary investigation (utilizing both an upper and lower body withdrawal) we confirmed, for the purpose of this study, that brain blood flow was accurately measured with a descending aorta reference catheter.
Preparation of tissues and analysis of data. At the end of the study the lambs were killed with a narcotic overdose. All catheter locations were visually identified at autopsy and the gastrointestinal contents removed. All organs were weighed and incinerated at 280" C for 72 h after which the ash was packed in counting vials. The amounts of each radionuclide in the organs and the reference arterial blood samples were measured with a well-type 7 scintillation counter (Model 1 185R, Searle Analytical) with a 1024-channel pulse-height analyzer (Ultima 11, Norland). Nuclide isotope separation was performed by a computer (Nova 3, Data General) using a previously verified (3) program.
Organ blood flow (Q,,,) was computed as follows:
where cpm,, is the radioactive cpm in the organ, cpmEf is the radioactive cpm in the reference arterial blood sample, Q, f is the reference arterial blood flow determined by calibrating the withdrawal pump. Cardiac output is the sum of all organ and carcass flows. Flows were calculated by dividing the organ flow (ml/min) by the weight (in 100 g). Oxygen delivery is the product of flow and O2 content expressed in the units ml 02/min/100 g. Left and right brain hemispheres and left and right kidneys were evaluated separately to establish adequate microsphere mixing in the arterial circulation (5, 1 1). The data were analyzed by comparing each organ flow (ml/ min/100 g tissue) at three time periods (baseline; hypoxia; hypoxia plus nitroprusside) using a two-factor analysis of variance without replication. If a given variable was not the same through all of the treatments, the Newman-Keuls test was used to distinguish which time period (treatment) was different from the others (24) . The same analysis was applied to the oxygen delivery data. All data are reported as means k SEM.
RESULTS
Hematocrits of the animals ranged from 28-36% at the start of the experiment and did not significantly decrease over the course of the study. Body weights ranged from 3.5 to 7.6 kg with a mean of 5.1 kg at the time of experimentation.
Data listed in Table 1 show that heart rate was not affected by the experimental conditions, while mean arterial pressure was significantly changed by nitroprusside infusion but not by hypoxemia. As expected, the lambs showed a significant decrease in both arterial oxygen content and oxygen tension while the inspired oxygen concentration was lowered. pH and Pco2 were not affected by the experimental conditions imposed.
Cardiac output was 326 k 37 ml/min/kg before hypoxemia and 392 k 59 ml/min/kg during hypoxemia, a change that was not significant. Five of the six lambs did, however, demonstrate a higher cardiac output during hypoxemia. With the addition of sodium nitroprusside, cardiac output fell to 304 k 58 ml/min/ kg, a decrease of 22% when compared to cardiac output during hypoxemia. This decrease was not significant by analysis of variance although cardiac output did decrease in each animal.
Changes in organ blood flow during this experiment are shown in Figure 1 . During hypoxemia blood flow to the heart, brain, and carcass increased, while blood flow to the stomach decreased. Blood flow to the small intestine and kidneys did not change significantly. During nitroprusside infusion, kidney and carcass blood flows decreased when compared to those same flows obtained during hypoxemia alone.
Hypoxemia caused decreased oxygen delivery to the kidneys, small intestine, and stomach (Fig. 2) . In the remaining organs, oxygen delivery was not changed by hypoxemia. Infusion of nitroprusside during hypoxemia significantly decreased oxygen delivery to the brain, kidney, and carcass (Fig. 2) .
During these experiments, there was no detectable cyanide present in whole blood, and thiocyanate concentrations were less than 1 mg/100 ml.
DISCUSSION
Acute hypoxemia in both newborn and adult animals has been consistently associated with circulatory changes so that oxygen delivery to the most metabolically active organs (such as heart and brain) is maintained. Increased cardiac output has been reported in the hypoxemic newborn lamb (1 3) and accounts, in part, for the increased blood flow needed to maintain oxygen delivery to these organs while changes in flow to other organs remain minimal. Although we did not demonstrate a significant increase in cardiac output during hypoxemia, our results remain compatible with previous studies. The changes in cardiac output seen by Sidi et al. (1 9) were also rather modest in I-wk-old lambs.
They attributed this difference in young lambs to the preexisting higher resting values. During infusion of nitroprusside to the hypoxemic lamb, cardiac output fell in each of the lambs and was accompanied by a significant decrease in blood pressure.
Reports from experiments with adult mammals (16) have shown that while nitroprusside is consistent in lowering arterial blood pressure, it causes variable changes in cardiac performance which are probably dependent on the preexisting cardiac performance state.
During arterial hypoxemia in the newborn, heart and brain receive an increasing fraction of the cardiac output. As arterial oxygen content falls, an increase in blood flow causes oxygen delivery to the myocardium and brain to remain constant. In the newborn lamb, 40-50% of the oxygen available to the cerebral circulation is extracted under normal circumstances (12) . Since increases in oxygen extraction are limited, adequate oxygen delivery is critical in maintaining normal cerebral oxygen consumption. We find that cerebral blood flow rose during hypoxemia so that oxygen delivery remained constant. When nitroprusside was infused, however, there was a small decrease in cerebral blood flow which led to a significant decrease in cerebral oxygen delivery. Thus, nitroprusside decreased the oxygen delivery to an important organ which has a limited ability to increase oxygen extraction and is, therefore, directly dependent on oxygen delivery for normal metabolic function. The circulatory adjustments of the neonatal gastrointestinal tract to arterial hypoxemia differ from those described for the brain. As arterial oxygen content decreases, there is a concurrent decrease in gastrointestinal blood flow (9) . Oxygen delivery, the product of arterial oxygen content and blood flow, must therefore also decrease. Previous studies have shown that increased oxygen extraction by the neonatal gastrointestinal tract allows for a stable oxygen consumption despite this decreased delivery. When oxygen content reaches a critical minimum, increased oxygen extraction is no longer possible and oxygen consumption falls as oxygen delivery decreases (9) . In the present study, hypoxemia decreased oxygen delivery to the stomach and small intestine. In order for normal aerobic metabolism to continue, oxygen extraction must have increased. The addition of nitroprusside to hypoxemia did not significantly change this decrease in oxygen delivery to the stomach. It was not possible, in these studies, to determine whether the stomach was near its maximal ability to extract oxygen during hypoxemia.
Total renal blood flow in neonatal lambs has been reported to decrease 25-35% during hypoxemia (23) . Although a decrease of a similar magnitude was possible but not significant in the present study, renal oxygen delivery fell significantly. The addition of nitroprusside resulted in a large additional decrease in renal oxygen delivery. Data are not available to assess the ability ofthe kidney in the newborn to maintain its oxygen consumption during periods of decreased oxygen delivery. However, in a manner similar to the gastrointestinal tract, the kidney may not be able to compensate for the large decrease in the delivery of oxygen found during nitroprusside infusion. Similarly, hypoxemia increased blood flow to the neonatal carcass so that oxygen delivery was maintained. Nitroprusside infusion caused a decrease in carcass oxygen delivery by decreasing carcass blood flow. Maintenance of normal metabolism again requires that either oxygen extraction increase or oxygen consumption fall.
To summarize, the infusion of a systemic vasodilator, nitroprusside, during a period of arterial hypoxemia produces a number of alterations in blood flow and oxygen delivery. Both the redistribution of cardiac output and the local tissue regulation of oxygen extraction act, in concert, to maximize organ oxygen availability during hypoxemia. Nitroprusside interferes with this physiologic adjustment by decreasing oxygen delivery to the brain. Those organs which increase oxygen extraction as their primary means of maintaining oxygen consumption such as the gastrointestinal tract, kidney, and carcass, may also be affected if the decrease in oxygen delivery exceeds their ability to extract sufficient oxygen.
Nitroprusside, when given intravenously, possibly combines with sulfhydryl groups in red cells and other tissues to release cyanide. Hepatic "rhodanase" then converts circulating cyanide to thiocyanate (2 1). Nitroprusside is usually given in higher doses and for a longer time than in the present experiment in order to cause accumulations of cyanide and thiocyanate. We were not able to detect cyanide or thiocyanate during our infusion of nitroprusside. Thus, the effects found on blood flow and oxygen delivery are due to nitroprusside and not the accumulation of toxic metabolites.
The relationship of the present experiment to the use of nitroprusside in the human neonate, although speculative, deserves comment. The use of nitroprusside has been proposed for circumstances such as persistent fetal circulation and respiratory distress syndrome in which hypoxemia is a prominent problem. We would expect, based on animal evidence, that the human neonate responds to hypoxemia by changing blood flow distribution so that oxygen delivery to heart and brain is maintained. Unless nitroprusside, when given to the hypoxemic neonate, causes an increase in arterial oxygen content, we expect that circulatory changes similar to those found in the present experiment could result in decreased cerebral oxygen delivery. Such a decrease in oxygen delivery in the susceptible newborn might increase the risk of hypoxic damage. Therefore, nitroprusside, and possibly other vasodilators as well (22) , should be used with caution in the hypoxemic newborn infant.
